Supernus Pharmaceuticals | SUPN - Actif À Court Terme





Actif À Court Terme Changement Date
Abbott USD 25.51B 488M 2026-03
ANI Pharmaceuticals USD 825.43M 78.35M 2026-06
Aurora Cannabis CAD 397.45M 48.38M 2026-03
Bristol-Myers Squibb USD 28.58B 1.37B 2026-06
Canopy Growth CAD 529.47M 4.8M 2026-03
Cara Therapeutics USD 25.33M 6.21M 2026-03
Corcept Therapeutics USD 439.68M 13.64M 2026-06
Eisai JPY 883.01B 121.38B 2026-06
Eli Lilly USD 64.67B 9.84B 2026-06
Novo Nordisk DKK 208.7B 31.38B 2026-06
Pacira USD 615.21M 100.25M 2026-06
Perrigo USD 2.45B 260.7M 2026-06
Pfizer USD 41.36B 1.46B 2026-06
Supernus Pharmaceuticals USD 723.5M 8.08M 2026-06
United Therapeutics USD 3.48B 611.7M 2026-06
Xeris Pharmaceuticals USD 274.76M 23.08M 2026-06